Clinical outcomes of left main coronary artery disease patients undergoing three different revascularization
Chieh-Shou Su1, Yu-Wei Chen, Ching-Hui Shen
1Cardiovascular Center, Taichung Veterans General Hospital, Taichung Institute of Clinical Medicine, and Department of Medicine, National Yang-Ming University School of Medicine, Taipei Division of Cardiology, Department of Internal Medicine, Taichung Veterans General Hospital Chiayi Branch, Chiayi Department of Anesthesiology, Taichung Veterans General Hospital, Taichung Department of Surgery Department of Medicine, National Yang Ming University School of Medicine, Taipei, Taiwan.
Insights
Robot-assisted coronary artery bypass grafting (R-CABG) showed lower mortality and shorter hospital stays for left main (LM) coronary artery disease patients compared to conventional CABG and PCI. R-CABG is a viable option for selected LM disease patients.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Interventional Cardiology
Background:
- Left main (LM) coronary artery disease significantly increases mortality and morbidity risk.
- Revascularization strategies for LM disease include percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG).
Purpose of the Study:
- To compare the clinical outcomes of PCI, conventional CABG (C-CABG), and robot-assisted CABG (R-CABG) in patients with LM disease.
Main Methods:
- Retrospective analysis of 472 LM disease patients undergoing PCI, C-CABG, or R-CABG between 2005 and 2013.
- Comparison of in-hospital and follow-up outcomes, including mortality, target vessel revascularization (TVR), and resource utilization.
Main Results:
- R-CABG group demonstrated significantly lower in-hospital and follow-up all-cause deaths compared to PCI and C-CABG groups.
- PCI group had the highest rate of TVR.
- R-CABG patients experienced shorter ICU and hospital stays and required less intra-aortic balloon pump support than C-CABG patients.
Conclusions:
- PCI may be suitable for older, comorbid patients with less complex LM disease.
- R-CABG is a feasible and effective alternative to C-CABG for stable LM disease patients, particularly those with high SYNTAX scores.
- Revascularization modality was not an independent predictor of long-term mortality in this real-world cohort.
Abstract:
Significant unprotected left main (LM) coronary artery disease is frequently associated with severe multivessel disease and increased mortality and morbidity compared with non-LM coronary artery disease. This study compared the clinical outcomes of patients with LM disease who received percutaneous coronary intervention (PCI) with stenting, conventional coronary-artery bypass grafting (C-CABG), and robot-assisted CABG (R-CABG).This retrospective study analyzed 472 consecutive LM disease patients who underwent three different revascularization approaches at a tertiary medical center between January 2005 and November 2013.Of the 472 LM disease patients, 139 received R-CABG, 147 received C-CABG, and 186 received PCI. The need for target vessel revascularization (TVR) was highest in the PCI group. The R-CABG group had significantly lower rates of in-hospital and follow-up all-cause deaths compared with the other 2 groups (1.4% vs. 3.4% and 9.7%, P = .0058; 13.7% vs. 29.3% and 29.6%, P = .0023, respectively). Patients in the R-CABG group had significantly lower rates of intra-aortic balloon pump assistance, and shorter duration of ICU and total hospital stay compared to patients in the C-CABG group. However, revascularization modality, SYNTAX scores, and residual SYNTAX scores were not independent predictors of in-hospital or long-term mortality.In this cohort of LM disease patients treated at a tertiary medical center, PCI is a reasonable choice in patients with less lesion complexity but who are older and have comorbidities. R-CABG is feasible in stable LM disease patients with high SYNTAX scores, and is an effective alternative to C-CABG in LM disease patients with few risk factors. However, revascularization modality per se was not a determinant for long-term mortality in our real-world practice.
Related Concept Videos
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation


